russ2000_2_0355|KNSA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
russ2000_2_0355|KNSA|1|Kiniksa Pharmaceuticals Ltd Total Current Assets (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Cash and Short Term Investments (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Inventories (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net PP&E (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Goodwill and Intangibles (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Current Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Long Term Liabilities (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Deposits (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Book Value (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Retained Earnings (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Treasury Stock (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd EV to Revenues|Kiniksa Pharmaceuticals Ltd EV to Earnings|Kiniksa Pharmaceuticals Ltd EV to Free Cash Flow|Kiniksa Pharmaceuticals Ltd EV to Assets (Quarterly)|Kiniksa Pharmaceuticals Ltd PS Ratio|Kiniksa Pharmaceuticals Ltd PE Ratio|Kiniksa Pharmaceuticals Ltd Price to Book Value|Kiniksa Pharmaceuticals Ltd PEG Ratio|Kiniksa Pharmaceuticals Ltd Debt to Equity Ratio|Kiniksa Pharmaceuticals Ltd Dividend Yield|Kiniksa Pharmaceuticals Ltd Shareholder Yield (TTM)|Kiniksa Pharmaceuticals Ltd Percent of Shares Outstanding Short|Kiniksa Pharmaceuticals Ltd Total Receivables (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Payables (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Total Capital Stock (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Return on Invested Capital|Kiniksa Pharmaceuticals Ltd Quality Ratio Score|Kiniksa Pharmaceuticals Ltd Momentum Score|Kiniksa Pharmaceuticals Ltd Beta (1Y)|Kiniksa Pharmaceuticals Ltd Sustainable Growth Rate (TTM)|Kiniksa Pharmaceuticals Ltd Institutional Investor Ownership Percentage|Kiniksa Pharmaceuticals Ltd Average Diluted Shares Outstanding (Quarterly)|Kiniksa Pharmaceuticals Ltd Total Employees (Annual)|Kiniksa Pharmaceuticals Ltd EPS Diluted (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd SG&A Expense (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Shares Outstanding|Kiniksa Pharmaceuticals Ltd Repurchase of Capital Stock (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Ordinary Shares Number (Quarterly)|Kiniksa Pharmaceuticals Ltd Payout Ratio|Kiniksa Pharmaceuticals Ltd Quick Ratio (Quarterly)|Kiniksa Pharmaceuticals Ltd Normalized Diluted EPS (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Stock Buybacks (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Effective Tax Rate (TTM)|Kiniksa Pharmaceuticals Ltd Return on Equity|Kiniksa Pharmaceuticals Ltd Net Income (TTM) (USD)|Kiniksa Pharmaceuticals Ltd Revenue (TTM) (USD)|Kiniksa Pharmaceuticals Ltd Dividend Per Share (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Revenue (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Gross Profit (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Pre-Tax Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Net Interest Income (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Price (USD)|Kiniksa Pharmaceuticals Ltd Total Return Price (USD)|Kiniksa Pharmaceuticals Ltd Enterprise Value (USD)|Kiniksa Pharmaceuticals Ltd 30-Day Average Daily Volume|Kiniksa Pharmaceuticals Ltd 1 Year Price Returns (Daily)|Kiniksa Pharmaceuticals Ltd Short Interest|Kiniksa Pharmaceuticals Ltd PE Ratio (Forward)|Kiniksa Pharmaceuticals Ltd PE Ratio (Forward 1y)|Kiniksa Pharmaceuticals Ltd PS Ratio (Forward)|Kiniksa Pharmaceuticals Ltd PS Ratio (Forward 1y)|Kiniksa Pharmaceuticals Ltd Quarterly EPS Estimates (USD)|Kiniksa Pharmaceuticals Ltd Quarterly Revenue Estimates (USD)|Kiniksa Pharmaceuticals Ltd Quarterly EPS Surprise|Kiniksa Pharmaceuticals Ltd Quarterly Revenue Surprise|Kiniksa Pharmaceuticals Ltd Quarterly Actual EPS (USD)|Kiniksa Pharmaceuticals Ltd Quarterly Actual Revenue (USD)|Kiniksa Pharmaceuticals Ltd Revenue Estimates for Current Fiscal Year (USD)|Kiniksa Pharmaceuticals Ltd Revenue Estimates for Next Fiscal Year (USD)|Kiniksa Pharmaceuticals Ltd Price Target (USD)|Kiniksa Pharmaceuticals Ltd Consensus Recommendation|Kiniksa Pharmaceuticals Ltd Price Target Num Estimates|Kiniksa Pharmaceuticals Ltd EPS Estimates for Current Fiscal Year (USD)|Kiniksa Pharmaceuticals Ltd EPS Estimates for Next Fiscal Year (USD)|Kiniksa Pharmaceuticals Ltd Research and Development Expense (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Reconciled Depreciation (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Non-Operating Interest Expense (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Land and Improvements (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Buildings and Improvements (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Other Properties (Quarterly) (USD)|Kiniksa Pharmaceuticals Ltd Machine, Furniture & Equipment (Quarterly) (USD)||
russ2000_2_0355|KNSA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
russ2000_2_0355|KNSA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0355|KNSA|5|91.2666666667|91.2666666667|91.5|91.2666666667|91.5|91.2666666667|91.2666666667|91.2666666667||91.2666666667|91.2666666667||||7.00512820513|92|||7.00512820513||92|1.45010615711||15.2386363636|92|91.2666666667|91.2666666667|||31.5333333333|30.5||30.5|91.3333333333|365.333333333|91.3333333333|91.3333333333|35.0555555556||91.2666666667||92|91.3333333333|91.3529411765|91.2666666667||91.2666666667|||92|91.4|91.3333333333|91.3333333333|91.3333333333|7.00512820513|7.00512820513|7.00512820513|7|7|15.2386363636|||1.44755244755|1.44712430427|91.3846153846|91.3846153846|91.375|91.5|91.375|91.375|21.54|21.5967741935|22.6949152542|10.8861788618|22.6949152542|17.0952380952|19.6911764706|91.3333333333|91.3333333333||||91.2727272727|91.2666666667||
russ2000_2_0355|KNSA|6|15|15|2|15|2|15|15|15||15|15||||195|1|||195||1|942||88|1|15|15|||30|32||14|18|3|18|18|36||15||1|18|17|15||15|||1|5|18|18|18|195|195|195|189|143|88|||286|539|13|13|8|2|8|8|50|62|59|123|59|63|68|18|18||||11|15||
russ2000_2_0355|KNSA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0355|KNSA|201703||||||||||||||||||||||||||||||||||32.467||-0.1522|1.903||||||-0.1522|||||||||-4.974|-4.941|0.074||||||||||||||||||||||||3.145|0.006|||||||
russ2000_2_0355|KNSA|201706||||||||||||||||||||||||||||||||||32.467||-0.3451|2.12||||||-0.3451|||||||||-11.239|-11.203|0.153||||||||||||||||||||||||9.272|0.006|||||||
russ2000_2_0355|KNSA|201709||||||||||||||||||||||||||||||||||32.467||-0.4937|2.241||||||-0.4937|||||||||-16.08|-16.029|0.169||||||||||||||||||||||||14.008|0.008|||||||
russ2000_2_0355|KNSA|201712|47.104|45.555||0.125||137.2|17.43|119.77||-89.708|-90.998|||||||||||||||1.218|0.001|||||||32.467|47|-1.0072|2.78|||46.963|||-1.0072||-0.0046||-64.874|||||-32.578|-32.701|0.133||||||||||||||||||||||||29.931|0.008|||||0.177||
russ2000_2_0355|KNSA|201803|222.453|221.108||0.126||19.298|19.268|0.03||205.477|-106.98||||-10.19||||4.0336|||||0.0194||2.796|0.011|||||||46.963||-0.3403|3.71|48.4408||46.963|||-0.3403||0.0224||-75.915|||||-16.035|-15.982|0.305|17.11|17.11|607.7141|||9387||||||||||||||||||12.63|0.008|||||0.168||
russ2000_2_0355|KNSA|201806|363.869|359.19||0.35||23.33|23.144|0.186||341.799|-127.239||||-9.8814||||3.9441|||||0.0254||0.561|0.013|||||||18.3284||-1.11|4.327|49.4472||49.4472|||-1.11|-159.193|0.2149||-84.971|||||-20.461|-20.259|1.066|16.73|16.73|589.3066|74945.8||12285|||||||||||||28.75|2|4||-2.703|17.2|0.012|||||0.184|13.77|21.69
russ2000_2_0355|KNSA|201809|341.528|337.863||2.36||28.188|28.021|0.167||318.913|-151.645||||-13.9439||||3.8068|||||0.9588||4.668|0.013|||||||48.1834||-0.51|5.515|49.4647||49.4647|||-0.51||0.2809||-93.348|||||-24.537|-24.406|1.622|26.31|26.31|941.9632|199836.9667||474187|||||||||||||33.5|2|4||-2.9|20.644|0.012|||||0.185|20.06|20.22
russ2000_2_0355|KNSA|201812|313.75|307.304||6.356||42.698|42.554|0.144||279.267|-194.225||||-11.436||||3.8576|||||1.0771||10.918|0.013|||||||49.4896|111|-0.88|8.013|49.4896||49.4896|||-0.88|-0.001|0.2069||-103.227|||||-42.408|-42.58|1.727|24.87|24.87|892.3639|114927.5||533036|||||||||||||34|2|4||-2.9811|36.122|0.254||||3.107|0.34|22.37|17.62
russ2000_2_0355|KNSA|201903|334.956|326.533||9.537||39.64|36.892|2.748||306.519|-260.046||||-7.809||||3.5136|||||1.5442||6.89|0.015||||-1.4734|||51.7584||-1.27|8.394|54.6928||54.6928|||-1.27|-83.106|0.1162||-153.066|||||-65.838|-65.821|1.809|18.06|18.06|673.9355|128381.9667|-10.8708|839015|||||||||||||30.8|2|5|-3.3205|-3.634|59.253|0.471||||6.673|0.359|15.65|15.94
russ2000_2_0355|KNSA|201906|296.458|287.447||8.862||32.94|30.178|2.762||275.197|-297.237||||-3.297||||2.5289|||||1.7714||9.338|0.015|||4|-1.5397|||54.4755||-0.68|8.441|54.8577||54.8577|||-0.68||0.2055||-169.998|||||-37.565|-37.191|1.724|14.17|14.17|448.6283|91202.5667|-19.0675|969008|||||||||||||31.25|2|4|-3.5267|-3.7986|30.848|0.508||||6.442|0.36|12.19|9.1
russ2000_2_0355|KNSA|201909|268.34|258.745||8.627||29.894|27.56|2.334||251.911|-324.295||||-1.0053||||1.6246|||||2||6.44|0.015|||2|-1.7569|||54.8313||-0.49|8.432|54.8713||54.8713|||-0.49||1.2701||-172.65|||||-29.06|-27.058|1.386|8.15|8.15|159.6433|89512.4667|-66.8567|1097431|||||-0.6985||29.8487||-0.49||||25|2|4|-2.925|-3.3686|22.014|0.523||||6.471|0.316|5.99|10.65
russ2000_2_0355|KNSA|201912|241.627|233.38||8.325||29.111|27.83|1.281||225.423|-356.092||||-2.2948||||2.549|||||2.3489||5.693|0.015|||2|-0.8363|||54.8969|137|-0.58|9.695|54.9376||54.9376|||-0.58||1.2488||-161.867|||||-31.451|-31.797|1.13|11.7|11.7|383.3662|290468.1667|-51.4925|1290456||||16.5355|-0.7601||23.6932||-0.58|||20.477|26.25|1.75|4|-3.27|-3.4036|22.886|0.566||||6.612|0.391|14.71|18.46
russ2000_2_0355|KNSA|202003|213.055|204.206||7.433||20.274|19.342|0.932||205.834|-382.511||||-2.8736||||3.095|||||3.3944||4.274|0.015|||7|0.0145|||55.3227||-0.48|8.486|55.5814||55.5814|||-0.48||3.3227||-122.465|||||-28.598|-26.419|0.789|12.56|12.56|464.2953|246676.7667|-24.3373|1886637||||23.4149|-0.616||22.0779||-0.48|||20.477|27.75|1.75|4|-2.785|-3.04|20.901|0.594||||6.334|0.391|21|21.76
russ2000_2_0355|KNSA|202006|264.493|252.398||6.533||21.025|20.552|0.473||250.416|-419.98||||-11.0045||||7.4039|||||4.6083||2.373|0.016|||9|1.1949|||57.9141||-0.65|9.536|60.4866||60.4866|||-0.65|-75.194|-1.6901||-122.743|||||-31.594|-37.469|0.266|25.48|25.48|1319.7736|273526.4|88.1832|2787410||||41.9421|-0.585||-11.1111||-0.65|||27.903|37.4|1.6|5|-2.474|-2.622|22.324|0.595||||6.029|0.391|20.09|17.8
russ2000_2_0355|KNSA|202009|378.413|364.395||5.739||25.904|24.892|1.012||358.509|-463.816||||-6.859||||4.2158|||||4.8538||3.925|0.018|||9|0.6035||65.8332|65.9585||-0.66|11.799|67.9172||67.9172|||-0.66|-146.475|-3.493||-139.521|||||-43.169|-43.836|0.049|15.55|15.55|803.2993|366702.4333|78.3257|3296570||||28.3159|-0.5925||-11.3924||-0.66|||24.6732|32.8|1.5|5|-2.37|-2.5075|31.419|0.649||||5.879|0.396|18.43|17.03
russ2000_2_0355|KNSA|202012|333.249|323.482||10.617||37.529|31.846|5.683||311.935|-517.473||||-6.8151||||3.3306|||||5.9062||0.503|0.018|||9|0.5583||73.5828|68.1074|168|-0.79|15.5|68.215||68.215|||-0.79||-3.2977||-161.381|||||-52.868|-53.657|0.03|17.54|17.54|829.6405|407717.7667|48.0342|4028902|||32.8026|9.9992|-0.6075||-30.0412||-0.79||15.1026|90.6823|32.8|1.4|5|-2.378|-2.0725|37.398|0.567||||11.168|0.411|19.72|21.84
russ2000_2_0355|KNSA|202103|275.564|264.025|2.189|9.797|20|40.462|35.453|5.009||270.696|-566.957||||-6.6575||||3.957|||||5.5257||2.763|0.018|||4|1.1054||72.4754|68.2695||-0.72|20.6|68.33||68.33|||-0.72||-4.2627||-184.446|||||-49.274|-49.484|0.009|18.09|18.09|910.8403|731405.7333|48.036|3775729|||34.4199|10.4922|-0.6267|7.775|-14.893|-100|-0.72||20.9473|91.847|34|1.4|5|-2.69|-2.2175|28.683|0.312||||10.584|0.411|16.68|13.28
russ2000_2_0355|KNSA|202106|244.81|225.866|6.381|8.835|19.75|43.423|38.782|4.641||235.785|-608.52||||-4.3351|2.6068|||3.6173|||||6.8287|2.551|4.156|0.018|||1|0.3791||66.7508|68.3957||-0.61|21.848|68.4647||68.4647||5.8898|-0.61||-1.4419||-188.54|||7.704|5.238|-40.549|-41.563|0.006|14.33|14.33|715.1726|456749.4333|-44.8846|4675276|||25.9543|7.9117|-0.775|3.9688|21.2903|94.1165|-0.61|7.704|20.2872|100.3502|32.6|1.4|5|-2.905|-1.968|23.945|0.717||||9.988|0.411|14.6|12.58
russ2000_2_0355|KNSA|202109|217.512|200.183|5.606|9.296|19.5|38.811|34.427|4.384||214.048|-639.064||||-3.2826|2.3114|||3.3886|||||5.2461|3.224|1.649|0.018|||2|0.7682||56.1191|68.6627||-0.44|20.759|68.8884||68.8884||5.9084|-0.44||-1.0931||-175.248|||12.095|9.328|-30.662|-30.544|0.005|11.66|11.66|573.1133|371339.2333|-24.3839|3613931|||21.3531|6.5091|-0.6275|10.1762|29.8805|18.8552|-0.44|12.095|31.7509|120.4529|29.8|1.4|5|-2.522|-2.008|19.236|0.658||||10.788|0.411|10.6|11.62
russ2000_2_0355|KNSA|202112|||||||||||||||-3.7639||||3.9039|||||3.2753||||||2|-0.7835||53.0619||||||||||||||||||||||12.13|12.13|635.4333|421611.1667|-29.9654|2256305|||6.6871|3.7026|-0.4025|17.5784|||||37.3984|122.0006|28.182|1.4|5|-2.1|-1.702||||||||10.9|10.72
russ2000_2_0355|KNSA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4767|18.701||||||||||||||||||||
russ2000_2_0355|KNSA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4267|25.103||||||||||||||||||||
russ2000_2_0355|KNSA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.4|30.0675||||||||||||||||||||
russ2000_2_0355|KNSA|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.3|44.642||||||||||||||||||||